Skip to content

Pharma analytical services

Our state-of-the-art laboratories, equipped with cutting-edge instrumentation such as UPLC, HPLC, LCMS, LC-MS/MS, LC-TOF-HRMS, GC, and GC-MS systems, are managed by an expert team of highly skilled and motivated professionals. This high-tech environment allows us to deliver advanced, top-quality pharmaceutical services, ensuring exceptional precision, reliability, and accuracy in our results.

banner_pharma3_vitas.png – Vitas Analytical Services
Anette Sauve – Vitas Analytical Services

Anette Sauve

Head of Pharma Services

as@vitas.no
+47 90 77 72 74
LinkedIn

Vitas offers an extensive portfolio of both GMP and non-GMP analytical services, catering to the pharmaceutical and nutraceutical industries. Our services span from single tests to comprehensive solutions including method development, validation, stability studies, release testing, tech-transfer, impurity characterization, high throughput analysis, along with necessary documentation and regulatory support.

Our laboratory is outfitted with the latest analytical equipment such as UPLC, HPLC, LCMS, LC-MS/MS, LC-TOF-HRMS, GC, GC-MS, ICP-MS, and dissolution systems, all operated by a team of highly skilled professionals. Each member of our team boasts an average of over 10 years of hands-on experience.

Our pharmaceutical analytical division is GMP-certified and regulated by the relevant authorities. Moreover, Vitas holds a manufacturing authorization for medicinal products from the Norwegian Medicinal Agency, testifying to our commitment to maintaining the highest quality standards.

Contact us to find out more about our Pharma Analytical Services.

Applications

Number Method
AM-638 Quantification of Tralopyril by LC-MS/MS
AM-617 Sulfated ash Ph.Eur 2.4.14
AM-611 Quantifiaction of tartrate in phenserine tartrate by LC-UV
AM-610 Elemental impurities in Phenserine tartrate by ICP-MS
AM-609 Quantification of water content in Phenserine tartrate using Karl Fischer
AM-601 Quantification of Human Insuline by HPLC-UV - USP
AM-587 Quantification of Zinc by ICP-MS in drug product and API
AM-586 Peptide Mapping of human insulin as per Ph.Eur 2.2.55 - 0838/2011
AM-585 Quantification of formaldehyde in API (N,N,N',N'-Ethylenediaminetetrakis (Methylenephosphonic Acid) by HS-GC-FID
AM-584 Quantification of trioxane in API (N,N,N',N'-Ethylenediaminetetrakis(Methylenephosphonic Acid)) by GC-FID
AM-582 Impurities with greater molecular mass than insulin in Human Insulin as per Ph.Eur 2.2.30 and 01/2011:0838
AM-580 Quantifative determination of Liothyronine in tablets
AM-579 Analysis of Co-codamol tablets assay
AM-578 Assay of human insulin by LC-UV Ph.Eur 2.2.29
AM-55X-G Quantification of NMBA (N-Nitroso-methyl-4-aminobutyric acidamine) in API and drug product by LC-MS/MS
AM-55X-F Quantification of NDBA (N-Nitroso-di-butylamine) in API and drug product by LC-MS/MS
AM-55X-E Quantification of NDiPA (N-Nitroso-di-isopropylamine) in API and drug product by LC-MS/MS
AM-55X-D Quantification of NDPA (N-Nitroso-di-propylamine) in API and drug product by LC-MS/MS
AM-55X-C Quantification of NEiPA (N-Nitroso-ethyl-isopropylamine) in API and drug product by LC-MS/MS
AM-539 Identification (ABC) of Quinine hydrochloridum Ph.Eur 01/2016:0018. European Pharmacopoeia 10.0
AM-533 Identification (D) of Magnesium Stearate Ph.Eur 01/2015:0229. European Pharmacopoeia 10.0
AM-520 Quantification of selected cytokines (IL-1beta, IL-6, IL-8, TNF-alfa) in CSF using MSD V-PLEX platform
AM-50x Quantification of chloride in corn steep liquor
AM-504 Quantitative determination of TPCS2a in human plasma using biphenyl column separation and UV detection
AM-502 Identification (ID) of thiamine hydrochloride using FT-IR
AM-501 Residual water: microdetermination by Ph.Eur 2.5.32 (Karl Fischer colorimetry)
AM-497 Identification of clonidine hydrochloride using FT-IR
AM-493 Analysis of etoricoxib in plasma by LC-UV-MS/MS
AM-491 Quantification of nitrosamines in API and drug product by LC-MS/MS
AM-489 Impurities in ethanol by GC-FID
AM-481 Quantification of trimethylbenzylammoniumion in eluates using LC-MS/MS
AM-480 Quantification of trimethylamine in eluates using LC-MS/MS
AM-462 Quantification of N-acetylneuraminic acid in formulation
AM-459 Plasmid topology analysis
AM-458 New method for analogues of exametazime by HPLC-UV
AM-456 Quantification of manganese in formulation by LC-ICP-MS
AM-453 Specific optical rotation
AM-452 Quantification of residual solvent ethanol and heptane in krill extracts
AM-448 Quantification of acetate in aqueous samples using GC-MS
AM-420 Quantification of fer-manganese in solution by UV
AM-419 Qunatification of residual solvent THF in powder using HS-GC-FID
AM-418 Quantification of cyclopentadien in powder by GC-FID
AM-416 Quantification of sodium ascorbate in formulation by LC-UV
AM-390 Quantification of OligoG in human/canine plasma using LC-MS/MS analysis
AM-387 Quantification of water content in granulate using coulometric Karl Fischer titration
AM-384 Particulate contamination: visible particles; 2.9.20
AM-383 Osmolality; Ph.Eur 2.2.35
AM-382 Potentiometric determination of pH; pH. Eur 2.2.3
AM-378 Quantification of Naloxone in human edta k2 plasma using LC-MSMS
AM-377 Quantification of EDTA in Naloxone nasal spray using HPLC-UV
AM-366 Determination of water content in combustion samples using colorimetric Karl-Fischer titration
AM-365 Determination of solvents in combustion samples using GC-FID
AM-362 Quantification of Naloxone in nasal spray by LC-UV
AM-323 Content of Astaxanthin, USP monograph Third Supplement, FCC8
AM-286 Detection of bromide in pharmaceutical formulation with ion selective electrode (ISE)
AM-244 Quantification of impurities in Cevira
AM-235 Quantification of oligoG in human plasma using LC-MS/MS analysis
AM-234 Quantitation of ioforminol using LC-FIA-UV (DAD)
AM-229 Quantitation of Ca-stearat in acetonitrile and acetonitrile/water extracts by GC-FID
AM-228 Quantitation of irganox 5057 using LC-UV (DAD)
AM-208 Quantitation of flutemetamol using LC-UV (DAD)
AM-206 Quantification of Methyl 5-aminolevulinate hydrochloride in plasma using LC-MS-MS
AM-197 pH measurement in liposomes
AM-196 Colour & clarity in liposomes
AM-194 Oligomers in liposomes by GC-FID
AM-193 Anisidine value (AV) in liposomes
AM-192 Peroxide value (PV) in liposomes
AM-191 HPLC method for identity, quantification of 1 mg folic acid (assay and interdose) in tablets
AM-190 Quantification of phospholipids in liposome formulation using HPLC-NQAD or ELSD
AM-189 Assay of elacytarabine and cytarabine using HPLC-UV
AM-187 Gross weight of capsule and net weight of capsule content in oil filled capsules
AM-181 Quantification of hydrocortisone, metagin, propagin, and impurities in cream by LC-UV
AM-173 Peroxide value (PV) in tablets and tablet powder by spectrophotometry
AM-167 Gravimetric quantification of dry residue after hot evaporation
AM-164 Quantification of acetic acid in ethanol by GC-FID
AM-131 Quantification of Hexyl 5-aminolevulinate in plasma
AM-128 Quantification of immunoglobulin G (IgG) by SEC-UV
AM-117 Quantification of TPCS2a in human plasma by HPLC-UV
AM-114 Quantification of bleomycin in human plasma by HPLC-FLD
AM-089 Quantification of emamectin benzoate by LC-UV-MS
AM-079 Quantification of DL-α-Tocopherol acetate in capsules using LC-UV
AM-078 Quantification of C-Vitamine in capsules using LC-UV
AM-058 Peroxide value (PV) in oil with AOAC Certified PeroxySafeTM Test kit
AM-049 Quantitative determination of the DOPE in liposomes by LC-MS (assay)
AM-048 Quantification of the DEPC in liposomes by LC-MS (assay)
AM-047 Quantification of DSPC in liposomes by LC-MS (assay)
AM-046 Quantification of DSPE in liposomes by LC-MS (assay)
AM-045 Quantification of cholesterol in liposomes by LC-UV
AM-044 Quantification of doxorubicin in liposomes by LC-UV (assay and purity)
AM-031 Quantification of ethanol and methanol in oil by GC-FID
AM-015 Preparative method, Hexyl 5-aminolevulinate (HAL) in plasma
AM-004 Analytical procedure for methyl 5-aminolevulinate hydrochloride in plasma
AM-003 Analytical procedure for dissolution of cholecalciferol in tablets by dissolution apparatus with paddle and HPLC
AM-002 Analytical procedures for identity, assay, degradation products in cholecalciferol concentrate (powder form)
AM-001 Analytical procedures for identification, assay, degradation products and UoC of cholecalsiferol in tablets by HPLC